About Genespire
Developing transformative gene therapies for people affected by genetic diseases
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B+
Global Headquarters
Milan, Italy
Team Size
1-10
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
genespire.com
Domain Registered Date
Oct 11, 2019
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $52,000,000 · Series-B+
fundraisingfox.com
- Capital Raise
Raised $17,347,200 · Series-A
- Milestone
Website domain registered
genespire.com
Investors & Backers
CDP Venture Capital
Indaco Venture Partners
Sofinnova Partners
XGEN Venture
Funding History
Series-B+
· Sep 25, 2024
$52,000,000 fundraisingfox.com
Series-A
· Apr 29, 2020
$17,347,200 Source
Founders & Leadership
Alessio Cantore
co-founder
Work email & phone locked
Unlock →
Julia Berretta
Chief Executive Officer
Work email & phone locked
Unlock →
Julianne Smith
Chief Development Officer
Work email & phone locked
Unlock →
Karen Pignet-Aiach
CEO
Work email & phone locked
Unlock →
Lucia Faccio
Chief Executive Officer
Work email & phone locked
Unlock →
Luigi Naldini
co-founder
Work email & phone locked
Unlock →
Philippe Mauberna
Chief Financial Officer
Work email & phone locked
Unlock →
Sabah Sallah
Chief Medical Officer
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026